Vanda Pharmaceuticals, Inc. (VNDA)

8.91 +0.31 (+3.60%) USD  |  NASDAQ  |  Feb 27, 16:00
8.86 -0.05 (-0.56%) After-Hours: 20:00
More

Vanda Pharmaceuticals Stock Based Compensation (5 Year Growth)

Stock Based Compensation (5 Year Growth) Chart

View Stock Based Compensation (5 Year Growth) for VNDA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (5 Year Growth) Range, Past 5 Years

View Stock Based Compensation (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (5 Year Growth) Benchmarks

View Stock Based Compensation (5 Year Growth) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Axsome Therapeutics, Inc. Upgrade
AnaptysBio, Inc. Upgrade
Gossamer Bio, Inc. Upgrade
Arcellx, Inc. Upgrade